Developer docs
API playgroundTry for free, no card

Search company profiles

Sandoz Canada

Full company profile

uuid000c2yu

Namestring
Sandoz Canada
Websiteurl
sandoz.ca
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Sandoz Canada is identified in the source data as a Canadian entity operating under the Sandoz brand, with a web presence at sandoz.ca. Beyond the company name and the URL, the available input does not describe what the company does, the products or services it offers, the technology it is built on, the customers it serves, or how it generates revenue. The source explicitly states that the parent company, founded date, legal name, operating status, company type, and ownership structure "cannot be determined from source data," and the ownership commentary notes that the source content contains only a page title and URL with no additional information. No office locations, management team, regulatory actions, certifications, patents, partnerships, customer logos, marketing channels, or distribution channels are populated in the input.

Because the source material is limited to a header and a URL with no substantive body content, the company description that can be supported by evidence is correspondingly thin. The verifiable facts are: the entity operates under the trade name "Sandoz Canada," it has a Canadian domain (sandoz.ca), and all structured enrichment fields — headcount, revenue, funding, products, leadership, partnerships, technology, and certifications — are empty in the provided records. Any further characterization of the company's business model, product surface, technology stack, or go-to-market would extend beyond the evidence in the input and has therefore been omitted.

Short descriptiontext

Sandoz Canada is a Canadian entity operating under the Sandoz brand with a web presence at sandoz.ca. The source data provides no substantive information about its products, services, technology, business model, or customer base.

Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBoucherville, Canada
HQ citystring
Boucherville
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
generic pharmaceuticals, prescription medicines, generic medications, pharmaceutical products, generic drug manufacturing
Product category
Generic Pharmaceuticals
Social media profiles1 record
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Sandoz Canada operates as the Canadian entity under the Sandoz brand, with a web presence at sandoz.ca. The provided source data does not contain specific details about its product or service offerings beyond the company name and website URL.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product and service information available in the provided source data.

No data
Peers9 records
TypeDirect peer
Description

Apotex is Canada's largest generic pharmaceutical manufacturer, headquartered in Toronto. It directly competes with Sandoz Canada across the Canadian generic prescription market and serves the same provincial formularies, wholesalers, and retail pharmacy customers.

TypeBroad incumbent
Description

Novartis Pharmaceuticals Canada is the Canadian subsidiary of Novartis, the former parent of Sandoz Group. Although Novartis focuses on innovative branded drugs (rather than generics) and Sandoz Canada focuses on generics and biosimilars, the two share historical corporate parentage and operate in adjacent therapeutic categories in the same Canadian market.

TypeDirect peer
Description

Auro Pharma is the Canadian operation of Aurobindo Pharma, an India-based global generic manufacturer. It competes with Sandoz Canada in Canadian generic prescription categories, particularly in cost-competitive tenders where low-cost API sourcing is a key advantage.

TypeDirect peer
Description

Viatris Canada is the Canadian arm of Viatris Inc., a global generics and specialty company formed from Mylan and Upjohn. It competes with Sandoz Canada across generic prescription, biosimilars, and specialty pharmaceutical categories in the Canadian market.

TypeDirect peer
Description

Teva Canada is the Canadian subsidiary of Teva Pharmaceutical Industries, one of the world's largest generic drug makers. It directly competes with Sandoz Canada in Canadian generic prescription and specialty categories, sharing similar multinational parentage and product breadth.

TypeOthers
Description

McKesson Canada is one of the largest pharmaceutical distributors in Canada, serving pharmacies, hospitals, and clinics. It is not a direct competitor but is a critical channel partner for Sandoz Canada, distributing its products across the Canadian retail and institutional pharmaceutical supply chain.

TypeDirect peer
Description

Pharmascience is a major privately held Canadian generic drug manufacturer based in Montreal. It competes head-to-head with Sandoz Canada in Canadian generic tenders, OTC products, and contract manufacturing, with similar customers and channel structure.

TypeOthers
Description

Loblaw, through its Shoppers Drug Mart and Pharma Prix banner network, is the largest retail pharmacy chain in Canada and a key customer channel for Sandoz Canada's generic and biosimilar products. It is not a direct competitor but represents one of the most important end-customer relationships in the Canadian drug supply chain.

TypeEmerging player
Description

Amgen Canada is the Canadian subsidiary of Amgen, a leading biotechnology company. It competes with Sandoz Canada's biosimilars portfolio in Canada, particularly as originator biologics face biosimilar competition, and it overlaps with Sandoz in therapeutic categories such as immunology and oncology.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses2 records

Each record includes

Headline, Details, Source

Key risks2 records

Each record includes

Headline, Details, Source

Key highlights2 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

No data
Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sandoz Canada

Generic Pharmaceuticalssandoz.ca

Sandoz Canada is a Canadian entity operating under the Sandoz brand with a web presence at sandoz.ca. The source data provides no substantive information about its products, services, technology, business model, or customer base.

What Sandoz Canada does

Sandoz Canada is identified in the source data as a Canadian entity operating under the Sandoz brand, with a web presence at sandoz.ca. Beyond the company name and the URL, the available input does not describe what the company does, the products or services it offers, the technology it is built on, the customers it serves, or how it generates revenue. The source explicitly states that the parent company, founded date, legal name, operating status, company type, and ownership structure "cannot be determined from source data," and the ownership commentary notes that the source content contains only a page title and URL with no additional information. No office locations, management team, regulatory actions, certifications, patents, partnerships, customer logos, marketing channels, or distribution channels are populated in the input.

Because the source material is limited to a header and a URL with no substantive body content, the company description that can be supported by evidence is correspondingly thin. The verifiable facts are: the entity operates under the trade name "Sandoz Canada," it has a Canadian domain (sandoz.ca), and all structured enrichment fields — headcount, revenue, funding, products, leadership, partnerships, technology, and certifications — are empty in the provided records. Any further characterization of the company's business model, product surface, technology stack, or go-to-market would extend beyond the evidence in the input and has therefore been omitted.

Sandoz Canada firmographics

Firmographics
Name
Sandoz Canada
Website
https://sandoz.ca
Company type
Private
Founded year
1980
Headcount range
251–500 employees
Short description
Sandoz Canada is a Canadian entity operating under the Sandoz brand with a web presence at sandoz.ca. The source data provides no substantive information about its products, services, technology, business model, or customer base.
Ownership category
akta.pro rank

Where Sandoz Canada is headquartered

Location

Headquarters

HQ city
Boucherville
HQ country
Canada
HQ region
North America

Markets served

Sandoz Canada business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Sandoz Canada product offering

Product offering

Core offering

Sandoz Canada operates as the Canadian entity under the Sandoz brand, with a web presence at sandoz.ca. The provided source data does not contain specific details about its product or service offerings beyond the company name and website URL.

Product overview

No product and service information available in the provided source data.

Differentiator

Problem solved

Functional benefit

Sandoz Canada technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sandoz Canada competitors and assessment

Company assessment

Direct peers

  • Apotex Inc. Apotex is Canada's largest generic pharmaceutical manufacturer, headquartered in Toronto. It directly competes with Sandoz Canada across the Canadian generic prescription market and serves the same provincial formularies, wholesalers, and retail pharmacy customers.
  • Auro Pharma Canada: Auro Pharma is the Canadian operation of Aurobindo Pharma, an India-based global generic manufacturer. It competes with Sandoz Canada in Canadian generic prescription categories, particularly in cost-competitive tenders where low-cost API sourcing is a key advantage.
  • Viatris Canada (formerly Mylan): Viatris Canada is the Canadian arm of Viatris Inc., a global generics and specialty company formed from Mylan and Upjohn. It competes with Sandoz Canada across generic prescription, biosimilars, and specialty pharmaceutical categories in the Canadian market.
  • Teva Canada: Teva Canada is the Canadian subsidiary of Teva Pharmaceutical Industries, one of the world's largest generic drug makers. It directly competes with Sandoz Canada in Canadian generic prescription and specialty categories, sharing similar multinational parentage and product breadth.
  • Pharmascience Inc. Pharmascience is a major privately held Canadian generic drug manufacturer based in Montreal. It competes head-to-head with Sandoz Canada in Canadian generic tenders, OTC products, and contract manufacturing, with similar customers and channel structure.

Broad incumbents

  • Novartis Pharmaceuticals Canada: Novartis Pharmaceuticals Canada is the Canadian subsidiary of Novartis, the former parent of Sandoz Group. Although Novartis focuses on innovative branded drugs (rather than generics) and Sandoz Canada focuses on generics and biosimilars, the two share historical corporate parentage and operate in adjacent therapeutic categories in the same Canadian market.

Others

  • McKesson Canada: McKesson Canada is one of the largest pharmaceutical distributors in Canada, serving pharmacies, hospitals, and clinics. It is not a direct competitor but is a critical channel partner for Sandoz Canada, distributing its products across the Canadian retail and institutional pharmaceutical supply chain.
  • Loblaw Companies (Shoppers Drug Mart): Loblaw, through its Shoppers Drug Mart and Pharma Prix banner network, is the largest retail pharmacy chain in Canada and a key customer channel for Sandoz Canada's generic and biosimilar products. It is not a direct competitor but represents one of the most important end-customer relationships in the Canadian drug supply chain.

Emerging players

  • Amgen Canada: Amgen Canada is the Canadian subsidiary of Amgen, a leading biotechnology company. It competes with Sandoz Canada's biosimilars portfolio in Canada, particularly as originator biologics face biosimilar competition, and it overlaps with Sandoz in therapeutic categories such as immunology and oncology.

Market position

Strengths3 records

Weaknesses2 records

Key risks2 records

Key highlights2 records

Customer concentration

Sandoz Canada social profiles

Digital presence

Sandoz Canada financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sandoz Canada leadership team

Management profile

Number of profiles

Sandoz Canada funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sandoz Canada M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sandoz Canada

What does Sandoz Canada do?

Sandoz Canada operates as the Canadian entity under the Sandoz brand, with a web presence at sandoz.ca. The provided source data does not contain specific details about its product or service offerings beyond the company name and website URL.

When was Sandoz Canada founded?

Sandoz Canada was founded in 1980. It employs 251 to 500 people.

Where is Sandoz Canada based?

Sandoz Canada is headquartered in Boucherville, Canada, in the North America region.

Who are Sandoz Canada's main competitors?

Direct peers on record are Apotex Inc., Auro Pharma Canada, Viatris Canada (formerly Mylan), Teva Canada and Pharmascience Inc.. Novartis Pharmaceuticals Canada is listed as a broad incumbent. Others are McKesson Canada and Loblaw Companies (Shoppers Drug Mart). Amgen Canada is listed as an emerging player.

Does Sandoz Canada have an API?

No public API is recorded for Sandoz Canada.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketScreenerSandoz wins Canadian approval for generic version of OzempicSandoz received Canadian approval for a generic version of Ozempic, a GLP-1 agonist for type 2 diabetes. The Canadian market is estimated at $2.6bn, with nearly 12 million semaglutide pens used annually. Sandoz said the decision does not affect its 2026 outlook, and a generic launch is not expected to make a material contribution this year.NewswirePublic Advisory - Two lots of Omnitrope injectable human growth hormone recalled due to cracked cartridgesSandoz Canada is recalling two lots of Omnitrope 5 mg/1.5 mL somatropin after complaints of cracked and leaking glass cartridges. The recall may cause contamination, infection, and lower doses. Health Canada is monitoring the recall and corrective actions.NewswireNeighbourhood Pharmacies Announces 2026 Award Recipients Celebrating Leadership and Innovation Across Canada's Pharmacy SectorNeighbourhood Pharmacies announced the recipients of its 2026 awards at the annual Chair's Dinner and Awards Ceremony during Pharmacy EXPO 2026 in Vancouver, recognizing outstanding leadership, partnership, and innovation across Canada's pharmacy sector. The awards included the Len Marks Pharmacy Advancement Award to Bruce Winston of Neighbourly Pharmacy, the Distinguished Partner of the Year Award to Michel Robidoux of Sandoz Canada, and the inaugural Sector Catalyst Award to Alicia Matthews-Kent of Neighbourly Pharmacy and Jason Wentzell of Extend Pharmacy Group. The ceremony celebrated contributions that are helping shape a stronger and more sustainable future for community pharmacy in Canada.BuycanadianinsulinWhich Companies Are Making Generic Semaglutide?As semaglutide patents expire across different countries, pharmaceutical companies are racing to develop and launch generic versions, with India having already seen multiple launches in March 2026 and companies in Canada, China, and Brazil filing for regulatory approvals. Dr. Reddy's Laboratories received Health Canada's first generic semaglutide approval in April 2026, while Sandoz, Apotex, Teva, Taro, and Aspen have also filed with Health Canada and expect launches in 2026. Chinese developers including Jiuyuan, Livzon, and CSPC are in Phase III trials with approvals expected later in 2026, and Brazilian companies Hypera and Biomm (partnering with Biocon) are pursuing filings with Brazil's health regulator.United News BangladeshPharmaceutical industry key sector for diversifying export basket: Health MinisterNevian Life Science PLC began exporting medicines to Canada under a contract manufacturing arrangement with Sandoz AG, marking the first time Bangladesh has exported pharmaceuticals to a highly regulated North American market. The initiative, held at Nevian's Tongi plant, is expected to expand to other Sandoz network countries.BioSpaceSandoz Canada launches first ophthalmology biosimilarSandoz Canada announced the launch of Enzeevu® (aflibercept), its first ophthalmology biosimilar, approved for all indications of the reference medicine EYLEA®, including neovascular age-related macular degeneration and diabetic macular edema. The biosimilar aims to improve affordability and access to retinal disease treatments for patients across Canada. This launch expands Sandoz's biosimilars portfolio into the ophthalmology therapeutic area, reinforcing the company's focus on affordable medicines.GlobeNewswireSandoz signs landmark supply and manufacturing agreementSandoz Canada signed a 10-year supply agreement with Delpharm to secure sterile injectables for Canadian hospitals. The partnership, backed by Canadian government funding, will modernize Delpharm's Boucherville plant, which produces 20 of Canada's top 100 molecules and the country's largest injectable narcotics capacity.GlobeNewswireSandoz Canada achieves carbon neutral certification for its commercial operationsSandoz Canada obtained carbon neutral certification from LCL Engineering for its Boucherville head office and business travel, offsetting emissions via carbon credits. The company also participated in the Mission 1000 tonnes initiative and switched to FSC-certified packaging for injectables.GlobeNewswireIntroducing Jubbonti® and Wyost®, the first denosumab biosimilars on the Canadian marketSandoz Canada launched Jubbonti and Wyost, the first denosumab biosimilars in Canada, with Jubbonti approved for osteoporosis and Wyost for bone metastatic cancers and giant cell tumors. Both are approved for all indications of their reference medicines, and Jubbonti is expected to be listed on all provincial formularies soon.GlobeNewswireImproving access for patients: launch of Lisdexamfetamine further broadens Sandoz Canada portfolioSandoz Canada launched PrSandoz Lisdexamfetamine, a generic equivalent of Vyvanse, for ADHD and binge eating disorder in adults. The launch is expected to generate savings of about $375 million for patients, governments, and insurers. The company also added three other generics this spring.